A1 · About · Value Chain Position · Scalability
EIC Framework · Distribution · Company Quality
Company Overview
Centum Electronics Limited (CEL) is a Bengaluru-headquartered Electronics System Design & Manufacturing (ESDM) company incorporated in 1993. It designs, develops, and manufactures mission-critical electronics for defence, space, aerospace, transportation, energy, healthcare, and industrial sectors.
Founded
1993 · Bengaluru
Employees
~2,000+
Promoter
Apparao V. Mallavarapu
HQ
Bengaluru, Karnataka
Business Segments
Margin Profile: BTS commands 20–25% EBITDA; EMS delivers 10–11% EBITDA but superior ROCE of 20–25%. ER&D is high-value, project-based.
Position in Defence Electronics Value Chain
🔬 R&D
DRDO / Labs
📐 Design
System Arch.
⚙ ESDM
Centum · CEL
🏭 EMS
Centum · CEL
🔩 Integration
HAL / BEL
🛡 Platform
Armed Forces
Centum occupies the critical mid-tier electronics manufacturing and design layer — between pure R&D and system integrators (HAL, BEL, DRDO). This is where indigenisation of defence electronics is most acute. The company's BTS model means it holds IP and supply-chain leverage, while the EMS model diversifies revenue with semiconductor and industrial customers.
A2 · Capabilities · Strategy
Core Capabilities
| Domain | Capability |
|---|---|
| 🛡 Defence | AESA Radar, Electronic Warfare, Avionics, Navigation |
| 🚀 Space | Hyperspectral Payloads, Satellite Electronics, ISRO programs |
| 🚢 Naval | Air Navigation Systems (GRSE partnership), Maritime electronics |
| ⚡ Semiconductor | EMS for global semiconductor equipment OEMs |
| 🔋 Energy | Power electronics, industrial embedded systems |
| 🚗 Mobility | Automotive electronics, transportation systems |
Strategic Pivot — India-First ESDM
Decisive restructuring: Exiting loss-making overseas operations (Canada fully exited; France under judicial reorganisation). One-time non-cash impairment of ₹153.8 Cr recognised in Q3 FY26. Post-restructuring, Centum transforms into a pure-play India ESDM company.
The multi-pronged strategy combines:
① Organic BTS growth — high-margin defence/space orders
② EMS scale-up — semiconductor equipment customer ($30M run-rate target)
③ Strategic partnerships — GRSE (naval), HAL (air)
④ AI / Automation investments — operational leverage
① Organic BTS growth — high-margin defence/space orders
② EMS scale-up — semiconductor equipment customer ($30M run-rate target)
③ Strategic partnerships — GRSE (naval), HAL (air)
④ AI / Automation investments — operational leverage
A3 · Opportunity — Why?
Addressable Market & Timeframe
India Defence Budget FY26
₹6.81L Cr
~13% YoY growth · 2.1% of GDP
↑ Electronics indigenisation drive
India ESDM Market by 2030
$300B+
Government PLI + Make-in-India push
↑ Domestic content mandate rising
HAL AESA Radar Prog. (Phase 2)
₹500 Cr
7-year program + Phase 1 ₹66 Cr
↑ L1 bidder declared
Opportunity Drivers
① Defence Indigenisation: India's 74% FDI limit + Positive Indigenisation Lists mandate Indian electronics. Centum is one of very few private players with certified BTS capability for airborne/naval platforms.
② Space Economy: ISRO commercialisation + private space (IN-SPACe) creates repeat demand for embedded electronics payloads. Centum has space heritage from multiple ISRO missions.
③ Semiconductor Equipment EMS: $30M annual run-rate target with a global semiconductor equipment customer — high ROCE, low capex expansion.
② Space Economy: ISRO commercialisation + private space (IN-SPACe) creates repeat demand for embedded electronics payloads. Centum has space heritage from multiple ISRO missions.
③ Semiconductor Equipment EMS: $30M annual run-rate target with a global semiconductor equipment customer — high ROCE, low capex expansion.
④ Naval Modernisation: GRSE partnership opens the Air Navigation programme (~₹500 Cr over 5 years). India's naval modernisation pipeline is multi-decade.
⑤ China+1 in EMS: Global OEMs seeking non-China manufacturing alternatives. Centum's EMS division positioned to capture share from Bengaluru facility.
Timeframe: FY27–FY30 is the inflection window as BTS programs ramp into serial production, overseas drag eliminated, and semiconductor EMS scales.
⑤ China+1 in EMS: Global OEMs seeking non-China manufacturing alternatives. Centum's EMS division positioned to capture share from Bengaluru facility.
Timeframe: FY27–FY30 is the inflection window as BTS programs ramp into serial production, overseas drag eliminated, and semiconductor EMS scales.
A4 · Operations · Ongoing & Upcoming Projects
Key Ongoing & Upcoming Programs
HAL AESA Radar — Utility Helicopter Maritime (UH-M)
₹66 Cr (Ph.1)
GRSE — Advanced Naval Air Navigation Systems
₹30 Cr (initial)
Global Semiconductor Equipment OEM — EMS Program
$10M (FY26)
Space — Hyperspectral Imaging Payload
TBD
Overseas Restructuring — Canada (exited) & France (in progress)
-₹154 Cr (one-time)
A5 · Financials & Growth · P&L
FY21–FY25 Annual + 9M FY26 Standalone
📸 TradingView — Dark Mode Chart (NSE:CENTUM)
FY25 Revenue
₹1,155 Cr
Consolidated
+6% YoY
9M FY26 Revenue
₹873 Cr
Consol. (₹630 Cr standalone)
+25% Standalone YoY
9M FY26 EBITDA
₹77.6 Cr
Consol. EBITDA margin 8.9%
SA margin 12.1% (+200bps)
Q3 FY26 SA Revenue
₹238 Cr
Standalone
+27% YoY
Q3 FY26 SA EBITDA
₹26 Cr
Standalone
+27% YoY
Annual P&L — Consolidated (₹ Crore)
| Year | Revenue | YoY % | EBITDA est. | OPM % | PAT | EPS (₹) | ROCE % |
|---|---|---|---|---|---|---|---|
| FY21 | 817 | Base | ~65 | 8.0% | +12 | 13.32 | 10.2% |
| FY22 | 780 | −4.5% | ~30 | 3.8% | −53 | −23.70 | 4.1% |
| FY23 | 923 | +18.3% | ~75 | 8.1% | +7 | 7.62 | 9.8% |
| FY24 | 1,091 | +18.2% | ~95 | 8.7% | −3 | 1.38 | 11.0% |
| FY25 | 1,155 | +5.9% | ~105 | 9.1% | −2 | 1.67 | 12.0% |
| 9M FY26 Latest | 873 | +21% est. | 77.6 | 8.9% | −53 (excl. one-time) | — | 12.0% |
Note: Q3 FY26 consolidated PAT of −₹61.75 Cr includes the ₹153.8 Cr one-time non-cash impairment of overseas subsidiary investments. Standalone operations delivered profitable EBITDA growth of 27% YoY. Adjusted for impairment, the underlying business trend is improving.
Revenue by Vertical (9M FY26)
Order Book Mix (Dec 2025 · ₹1,700 Cr)
Order book of ₹1,700 Cr = ~1.5x trailing revenue. BTS at 49% ensures high-margin pipeline dominance. New HAL + GRSE wins will further skew towards BTS.
📸 TradingView — Fundamentals Layout (NSE:CENTUM)
A6 · Regulatory Changes & Impact
Regulatory Tailwinds & Changes
| Regulation / Policy | Impact on Centum | Status |
|---|---|---|
| Defence Acquisition Procedure (DAP 2020) | Preference for Indian vendors; Centum qualifies for "Make-II" category | Positive |
| Positive Indigenisation List (PIL) | 500+ defence items mandated for domestic production — Centum addressable in radar, comms, avionics | Positive |
| PLI for Advanced Chemistry / Electronics | EMS division eligible; lowers cost competitiveness gap vs imports | Positive |
| IN-SPACe / ISRO Commercialisation | Privatisation of space sector creates new pipeline beyond ISRO direct — Centum well-positioned | Positive |
| 74% FDI Cap in Defence | Favours domestic players like Centum over pure foreign players | Positive |
| GST Compliance | Defence contracts often delayed by IGST complexities — execution risk | Neutral/Watch |
| Offset Policy Revisions | Any relaxation of offset requirements could reduce captive domestic orders | Watch |
A11 · Order Book Tracker
Growing or Falling — Inflow Trend
Order Book (Dec 2025)
₹1,700 Cr
~1.47x FY25 revenue
↑ Growing
HAL AESA Pipeline
₹566 Cr
Ph.1 ₹66 Cr + Ph.2 ₹500 Cr est.
↑ Declared L1
GRSE Naval Pipeline
₹530 Cr
₹30 Cr booked + ₹500 Cr pipeline
↑ Partnership active
Order Book Trend (Indicative · FY22 → Dec 2025)
FY22
~₹600
FY23
~₹800
FY24
~₹1,100
FY25
~₹1,350
Dec'25
₹1,700 Cr
Order book has compounded at ~30% from FY22 to Dec 2025, reflecting consistent deal-flow. New HAL AESA Phase 2 (₹500 Cr) and GRSE pipeline (₹500 Cr) could push total potential pipeline to ₹2,700 Cr+ by FY27.
Recent Major Order Wins
| Date | Customer | Order / Program | Value | Duration | Status |
|---|---|---|---|---|---|
| Feb 2026 | HAL | AESA Radar — UH-M (Phase 1) | ₹66 Cr | 2 years | Active |
| Feb 2026 | HAL | AESA Radar — UH-M (Phase 2 pipeline) | ₹500 Cr | 7 years | Pipeline |
| Q3 FY26 | GRSE | Advanced Naval Air Navigation Systems | ₹30 Cr | Till Feb 2028 | Active |
| Q3 FY26 | Global Semi OEM | EMS for Semiconductor Equipment | $10M FY26 | Ongoing | Serial Prod. |
| FY25 | Various | Defence / Radar (L1 bidder) | ₹700 Cr | 5-6 years | L1 Declared |
A8 · Balance Sheet · Cash Flows · Fraud Filter
Total Assets (FY25)
₹1,239 Cr
Consolidated
Borrowings
₹187 Cr
FY25 Consolidated
D/E moderate
Equity + Reserves
₹406 Cr
₹15 Cr capital + ₹391 Cr reserves
Book Value / Share
₹274
P/BV at 10.2x
High P/BV vs. profitability
Balance Sheet Health
🔍 Fraud Filter Checklist
| Signal | Status | Note |
|---|---|---|
| Promoter pledge | Clean | No significant pledge reported |
| Related party transactions | Monitor | Promoter family holds key roles — standard watch |
| Auditor changes | Stable | No recent adverse auditor change |
| Contingent liabilities | Watch | France restructuring risk |
| Receivables vs. Revenue | Elevated | Defence payment cycles are long — structural |
| Overseas write-off | One-Time | ₹153.8 Cr impairment — fully recognised, non-cash |
| Cash from operations trend | Improving | Standalone CFO improving as BTS ramps |
Cash Flow Assessment
Key Observation: Consolidated CFO has been negative or thin historically due to overseas operations drag and long defence procurement cycles. However, standalone (India) operations CFO is improving as serial production of defence/EMS contracts ramps. The ₹153.8 Cr write-off is non-cash and does not impact liquidity. Post-restructuring balance sheet cleans up significantly. Watch for working capital normalisation as defence order execution scales.
A10 · Valuations · Research Reports Data Mix
Market Cap
₹4,109 Cr
P/E (TTM)
73.9x
High — reflects turnaround story optionality
P/BV
10.2x
Book ₹274/share
EV/Sales (FY25)
~3.6x
Moderate for defence ESDM
Valuation Framework
Valuation Context: At ₹4,109 Cr market cap and ~₹1,155 Cr revenue (FY25), Centum trades at ~3.6x EV/Sales. For a company undergoing a meaningful turnaround with BTS margins of 20–25% targeted and overseas drag eliminated, this is a forward-looking multiple. Comparable defence ESDM peers (BEL at ~4x, Data Patterns at ~8x sales) suggest the market is pricing in moderate execution. The key re-rating catalyst is: sustained standalone profitability + large order execution.
| Metric | Centum | BEL (Large cap) | Data Patterns | Comment |
|---|---|---|---|---|
| Mkt Cap | ₹4,109 Cr | ₹1.8L Cr | ₹4,200 Cr | Peer size |
| P/E | 73.9x | 34x | 55x | Centum at premium on recovery narrative |
| P/Sales | ~3.5x | ~5x | ~12x | Centum cheaper on sales basis |
| ROCE | 12% | 32% | 28% | Centum needs to close the gap |
| Revenue CAGR 3Y | +14% | +17% | +18% | Growth broadly comparable |
A7 · Research Reports & Data Mix
Analyst Coverage & Consensus
Centum Electronics is lightly covered — characteristic of mid/small cap defence ESDM. Coverage is primarily from smaller brokerages and PE-focused research. A January 2026 downgrade to 'Sell' was noted amid overseas restructuring concerns; however, Q3 FY26 management commentary has been constructively received. The stock's narrative is transitioning from "loss-making overseas drag" to "pure-play India defence ESDM turnaround." Watch for analyst upgrades as France restructuring resolves and Q4 FY26/FY27 numbers demonstrate standalone momentum.
| Source | View | Key Catalyst Cited |
|---|---|---|
| Broker Downgrade (Jan 2026) | Sell | Overseas losses, impairment, consolidated PAT negative |
| Management Guidance (Q3 FY26) | Positive | SA growth 27%, EBITDA up, order wins, restructuring complete |
| Order Flow Signal (Feb 2026) | Positive | HAL AESA ₹66 Cr + L1 for ₹700 Cr programme |
| Investor Presentation Mar 2026 | Constructive | Semiconductor EMS $10M FY26, run-rate $30M target |
A15 · Ownership · Promoter + FII/DII Pattern
Smart Money Moving In or Out?
Shareholding Pattern — Dec 2025
Promoters
46.89%
▼4.63% (6M)
DII (incl. MF)
19.95%
▲11.85% (12M)
Public
30.78%
→ stable
FII / FPI
2.39%
▲1.59% (12M)
Quarterly Trend (6Q Analysis)
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Dec 2024 | 58.80% | 1.00% | 8.10% | 32.10% |
| Mar 2025 | 51.52% | 0.80% | 15.40% | 32.28% |
| Jun 2025 | 51.52% | 1.90% | 15.70% | 30.88% |
| Sep 2025 | 46.99% | 2.85% | 19.30% | 30.86% |
| Dec 2025 Latest | 46.89% | 2.39% | 19.95% | 30.78% |
Smart Money Signal Analysis
Promoter Dilution — High Alert
Promoter holding fell from 58.80% (Dec 2024) to 46.89% (Dec 2025) — a −11.91% drop in 12 months. Apparao V. Mallavarapu remains the primary holder at 35.5%. This dilution warrants monitoring — likely driven by secondary market sales, not business concerns per se.
Key promoter individuals: Apparao V. Mallavarapu (35.50%), Nikhil Mallavarapu (4.43%), Tanya Mallavarapu (4.37%), Swarnalatha Mallavarapu (2.51%).
✅
DII Accumulation — Positive Signal
DIIs have aggressively accumulated — from 8.10% (Dec 2024) to 19.95% (Dec 2025) — a +11.85% increase. Mutual fund holdings rose from 4.68% to 10.27%. Domestic institutional conviction is building.
📈
FII Re-entry — Watch
FIIs added from 1.0% to 2.39% over the year — early signs of foreign interest returning. Still very low absolute level — significant room for FII accumulation if turnaround narrative solidifies.
A12 · Track Record · Management Quality
Management Quality Assessment
Key Management Commentary (Q3 FY26 Concall)
"This quarter represents an important inflection point. We have taken decisive restructuring actions to strengthen our core India ESDM platform. We do not expect any further material financial impact beyond what has already been recognised."
— Management, Q3 FY26 Earnings Call
"Build-to-spec programs are delivering 20–25% EBITDA margins. Our EMS division provides superior ROCE of 20–25% at 10–11% EBITDA. The combination de-risks the portfolio while maximising capital efficiency."
— Management, Investor Presentation March 2026
"Serial production has started with our semiconductor equipment customer in Q3 FY26. We target $10 million for FY26 and a $30 million annual run-rate within two years."
— Management, Q3 FY26 Concall
Track Record — Milestones & Execution History
| Year | Event | Outcome |
|---|---|---|
| FY21 | Revenue ₹817 Cr, profitable (PAT +₹12 Cr) | Positive |
| FY22 | Loss of ₹53 Cr — overseas drag + COVID tail | Negative |
| FY23 | Recovery — revenue +18%, marginal profit | Recovery |
| FY24 | Revenue ₹1,091 Cr (+18%), thin losses | Mixed |
| FY25 | Revenue ₹1,155 Cr — overseas drag persists | Mixed |
| Q3 FY26 | SA +27% revenue/EBITDA; restructuring actioned; HAL/GRSE wins | Improving |
| Feb 2026 | HAL AESA order ₹66 Cr + L1 for ₹700 Cr programme | Positive |
A13 · Issues & Risks · A14 · Key Milestones to Track
KEY RISKS
France Subsidiary Restructuring Uncertainty
French unit under judicial reorganisation. 4–6 months for clarity. Although mgmt says no further material impact, headline risk remains. Any adverse outcome could impact consolidated numbers.
Promoter Stake Dilution
Promoter holding declined from 58.8% to 46.89% in 12 months — a significant 11.9% reduction. Continued selling by promoters could signal lack of confidence or funding needs.
Defence Order Execution Delays
Indian defence procurement is notoriously slow. Phase 2 of AESA radar (₹500 Cr) may face delays in contracting. Revenue recognition from BTS orders is lumpy and back-end loaded.
Valuation Risk — High Multiples on Recovery Story
P/E 73.9x and P/BV 10.2x are demanding for a company with negative ROE. Any execution disappointment could de-rate sharply. The stock has already corrected from ₹3,044 (52W high) to ₹2,787.
Revenue Concentration & Customer Risk
Semiconductor EMS revenue at $10M FY26 is from a single global OEM. BTS programmes concentrated in HAL/DRDO ecosystem. Single-customer dependency amplifies volatility.
Working Capital Pressure
Defence payment cycles are long (90–180 days). As Centum scales BTS orders, working capital intensity will increase. Monitor receivables / revenue ratio quarterly.
KEY MILESTONES TO TRACK
🎯
France Restructuring Resolution (Q1-Q2 FY27)
Clarity on French subsidiary outcome. Positive resolution removes consolidated drag permanently and improves balance sheet quality.
📋
HAL AESA Phase 2 Contract Signing
₹500 Cr, 7-year programme. Once formally awarded (Centum is L1), this locks in ~0.5x FY25 revenue for 7 years. Major de-risking event.
💲
Semiconductor EMS $10M → $30M Ramp
Track quarterly EMS revenue growth. Achieving $30M run-rate by FY28 would add ~₹250 Cr to standalone revenue. Watch for volume ramp confirmation each quarter.
🏭
Standalone PAT Turning Consistently Positive
Standalone EBITDA is already positive and growing. First sustained quarterly PAT positive quarter (adjusted for impairments) is the fundamental inflection trigger.
📈
Order Book Crossing ₹2,500 Cr
With HAL Phase 2 + GRSE full pipeline + new wins, order book at ₹2,500 Cr+ would imply 2x+ book-to-bill and remove growth uncertainty for 2–3 years.
👥
Promoter Buying / Stabilisation
Any cessation or reversal of promoter selling would be a strong conviction signal. Track shareholding pattern each quarter.
Part B · Technicals · Chart Analysis
Price Action · Momentum · Levels · R:R
B0 · Stage Analysis & Setup
⚙ Stage 3 → Stage 4 Transition Watch · Possible Base Formation
Setup Characterisation: CENTUM is trading at ₹2,787, having declined from its 52W high of ₹3,044 (~8.5% off highs). The stock made a 52W low of ₹1,140 and has more than doubled since then — now in a Stage 3 distribution / consolidation phase. The key question is whether the current pullback from ₹3,044 is a healthy correction within Stage 2 (constructive — cheat entry zone) or the beginning of a Stage 3/4 breakdown. Given the strong standalone fundamentals improvement (Q3 FY26 SA +27% YoY) and new order wins, the fundamental case supports the former.
Current Setup
Pullback / Base
Post-breakout consolidation from 52W lows
Stage
Stage 2-3
Watch for Stage 2 continuation vs. Stage 4 start
52W Range
₹1,140 – ₹3,044
CMP ₹2,787 = 82% off lows, 8.5% below highs
📊 Live TradingView Chart — NSE:CENTUM (Embedded)
Interactive chart courtesy TradingView · Weekly candle view · Dark mode
B1 · Momentum + Volume + Price Action
| Indicator | Reading | Signal |
|---|---|---|
| 52W High / Low | ₹3,044 / ₹1,140 | Near-high territory |
| CMP vs 52W High | −8.5% | Pullback zone |
| CMP vs 52W Low | +144% | Strong uptrend from lows |
| Recent Volume (Q) | 42,670 (Apr 6) | Below avg — watch for surge |
| Price Change (Day) | −₹49.40 (−1.74%) | Mild weakness |
| Trend Direction (1Y) | Up (+144% off lows) | Primary uptrend intact |
B2 · Key Price Levels
RESISTANCE 2 · 52W High
₹3,044
RESISTANCE 1 · Recent High Zone
₹2,819 – ₹2,900
CURRENT PRICE
₹2,787
SUPPORT 1 · Key S Zone
₹2,458 – ₹2,527
SUPPORT 2 · Important Structure
₹2,060 – ₹2,217
HARD STOP · Thesis Invalidation
₹1,840
B3 · Trend + Relative Strength
Primary Trend: Bullish (up ~144% from 52W lows). Stock has outperformed broader markets significantly on the recovery trade.
Relative Strength: CENTUM has demonstrated significant alpha vs. Nifty Small Cap 250 index on the run from ₹1,140. However, near-term RS has softened as stock consolidates below ₹3,044 resistance.
Sector RS: Defence/ESDM sector (GRSE, HAL, Data Patterns) has broadly been in favour. Centum is a laggard within defence peers given overseas drag — potential catch-up play as fundamentals improve.
Relative Strength: CENTUM has demonstrated significant alpha vs. Nifty Small Cap 250 index on the run from ₹1,140. However, near-term RS has softened as stock consolidates below ₹3,044 resistance.
Sector RS: Defence/ESDM sector (GRSE, HAL, Data Patterns) has broadly been in favour. Centum is a laggard within defence peers given overseas drag — potential catch-up play as fundamentals improve.
B4 · Risk:Reward (Indicative)
Reward to S1 (₹2,819)
+1.2%
Near-term breakout above resistance
Risk to Hard Stop (₹1,840)
−34%
Full thesis invalidation level
R:R (₹3,200 target / ₹2,458 stop)
~1.5:1
Modest — better entry at S1 zone ₹2,460
⚠ R:R improves significantly on a pullback to ₹2,460–₹2,527 zone. R:R at current price (₹2,787) is not compelling unless breakout above ₹3,044 confirms.
B5 · Entry / Exit / Milestones
| Scenario | Level | Type |
|---|---|---|
| Cheat Entry (Pullback) | ₹2,460 – ₹2,527 | Add zone |
| Breakout Entry | ₹3,050+ (close) | Episodic pivot |
| Current Price | ₹2,787 | Hold zone |
| Target 1 | ₹3,200 – ₹3,400 | First T |
| Target 2 (FY27) | ₹4,000+ | Re-rating T |
| Stop (Thesis) | ₹2,200 (weekly close) | Soft stop |
| Hard Stop | ₹1,840 (close) | Exit all |
⚠ Important Disclaimer — Primaegis Research
This report is a research and structured thinking document only, produced by Primaegis Research for internal analytical purposes. Neither Primaegis nor any associated individual is a SEBI registered investment advisor. Nothing in this report constitutes investment advice, a recommendation, or a solicitation to buy, sell, or hold any security, fund, or financial instrument. All data is sourced from publicly available information including company filings, investor presentations, concall transcripts, and financial databases as of the research date. Past performance of any company mentioned does not indicate future results. Markets carry risk. Always conduct your own due diligence and consult a SEBI registered investment advisor before making any financial decision. All price levels and technical analysis are for research framing only — not trading recommendations.
Report Date: April 6, 2026 · Research: Primaegis Research · Data Sources: Company Filings, BSE/NSE, Concall Transcripts (Q3 FY26), Investor Presentation (Mar 2026), Screener.in, TrendLyne, AlphaSpread